• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[Characteristics and the use of blood transfusions and blood components in patients with hemostasis disorders. I. Transfusion of blood and plasma].

作者信息

Grgicević D, Pistotnik M

出版信息

Lijec Vjesn. 1986 Feb-Mar;108(2-3):92-5.

PMID:3959742
Abstract
摘要

相似文献

1
[Characteristics and the use of blood transfusions and blood components in patients with hemostasis disorders. I. Transfusion of blood and plasma].止血障碍患者输血及血液成分的特点与应用。I. 血液及血浆输注
Lijec Vjesn. 1986 Feb-Mar;108(2-3):92-5.
2
[Characteristics and use of blood transfusion and blood components in the treatment of patients with hemostasis disorders: II. Levels of coagulation factors].[止血障碍患者治疗中输血及血液成分的特点与应用：II. 凝血因子水平]
Lijec Vjesn. 1986 Jun;108(6):274-7.
3
Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies.用盐酸氨甲环酸（S-59）光化学病原体灭活法制备的新鲜冰冻血浆：用于先天性凝血因子缺乏患者的输血治疗
Transfusion. 2005 Aug;45(8):1362-72. doi: 10.1111/j.1537-2995.2005.00216.x.
4
Protocol and preliminary results of a clinical study for comparison of solvent/detergent-inactivated plasma VIP versus FFP with special consideration of the balance of hemostasis.一项关于溶剂/去污剂灭活血浆VIP与新鲜冰冻血浆比较的临床研究方案及初步结果，特别考虑了止血平衡
Beitr Infusionsther Transfusionsmed. 1994;32:440-4.
5
Transfusion therapy in acquired coagulopathies.获得性凝血障碍的输血治疗。
Hematol Oncol Clin North Am. 1994 Dec;8(6):1181-201.
6
[Indications of the different components of blood and outcome of transfusion practices in postpartum hemorrhage].[产后出血中血液不同成分的指征及输血实践的结果]
Cah Anesthesiol. 1994;42(3):385-9.
7
[Status of "blood coagulation active human citrate plasma" within the scope of blood component therapy].
Z Arztl Fortbild (Jena). 1987;81(22):1151-4.
8
[Directions for blood component therapy in blood coagulation disorders].[凝血障碍的血液成分治疗指南]
Klin Anasthesiol Intensivther. 1980;21:136-51.
9
[Hemostasis disorders and their correction in the early postoperative period in patients with pulmonary diseases].
Probl Tuberk. 1994(3):24-6.
10
Therapeutic indications for platelets, plasma and plasma derivatives in the neonate.
Mead Johnson Symp Perinat Dev Med. 1986(28):55-60.